3 ms·
Sofosbuvir, the Hepatitus C cure, was developed by Pharmasset before it was acquired by Gilead for $11.2 billion. Gilead paid for the later stage clinical trial
by civilitty 8y ago
Sofosbuvir, the Hepatitus C cure, was developed by Pharmasset before it was acquired by Gilead for $11.2 billion. Gilead paid for the later stage clinical trials but by then it had already been tested in humans and it was obvious to pretty much everyone that Sofosbuvir was something of a miracle drug. The time from discovery to marketing approval was only six years which is an almost unheard of pace.
- wbl 8y agoGilead spent $11 billion, some of which went to compensating Pharmassset investors who put up a lot of money to make it happen. And crashing in Phase 3 is not unknown: Pfizer has lost how much on Alzheimers? Plus toxicity and rare side effects can doom drugs.